| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |